Flu treatment study for children ages 2 to 12
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests a new oral medicine (JKN2301) for children with the flu. It aims to see if the medicine is safe and works well to treat flu symptoms like fever and cough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 2 and under 12 years old.
- They must have flu symptoms (like fever and cough or runny nose) and a positive flu test.
- Treatment must start within the first few days of symptoms.
- They need to be able to swallow an oral suspension (liquid medicine).
- Your child should not have severe flu signs needing hospital care, a bacterial infection needing antibiotics, or a weak immune system.
- They must not have taken other flu antiviral medicines recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study compares antiviral medicines in adults who have early, flu-like symptoms and test positive for influenza. It aims to see which antiviral treatment works best and is safe for people treated soon after symptoms start.
This study tests an investigational flu medicine (called Suraxavir Marboxil) for children with the flu. The goal is to see if it safely and effectively treats flu symptoms and shortens the illness.
This study tests an experimental antiviral pill called Onradivir for teenagers (ages 12 to 17) with uncomplicated influenza A. It aims to see if the drug can safely shorten flu symptoms and help you recover faster.
This trial tests an oral tablet (SYH2085) to see if it can help adults with the flu feel better faster. If you join, you'll either get the study drug or a placebo (a pill with no medicine).
This study measures how your child's body builds immunity after receiving a nasal spray flu vaccine. Researchers will collect samples to understand how the vaccine triggers the immune system to protect against influenza.
This study tests an experimental medicine called TRX-100 to see if it can safely treat the flu. Healthy volunteers will be given the flu virus in a controlled setting, then the medicine, to see how well it works.
Hear when a new Respiratory Viral Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.